+1 877 705 1914• 24 / 7
HIPAA Compliant
ISO 27001 Certified

Actively Recruiting

Phase 4
Age: 18Years - 75Years
All Genders
ID05410925

Safety and Effectiveness of Half-Dose Recombinant Staphylokinase Before Primary PCI for ST-Elevation Myocardial Infarction A Multicenter Randomized Placebo-Controlled Trial

Led by The First Affiliated Hospital with Nanjing Medical University · Updated on 2026-10-30

2260

Participants Needed

61

Research Sites

52 weeks

Total Duration

AI-Summary

What This Trial Is About

Researchers are evaluating the safety and effectiveness of a half-dose bolus of recombinant staphylokinase r-SAK given before primary percutaneous coronary intervention PCI in patients with acute ST-segment elevation myocardial infarction STEMI. This phase 4, multi-center, randomized, double-blind, placebo-controlled trial aims to determine whether adding r-SAK immediately before PCI improves outcomes compared to placebo within 120 minutes of the procedure. The study is motivated by the need to improve early reperfusion and reduce heart damage in STEMI patients. Participants are randomly assigned to receive either a single intravenous bolus of 5 mg r-SAK over 3 minutes or a placebo injection within 10 minutes after STEMI diagnosis and before PCI. The trial compares these two groups to assess the impact on major adverse cardiovascular events MACE within 90 days. The study also monitors other heart and brain event outcomes, heart function measures, and blood flow grades before and after PCI. During the study, participants undergo assessments including cardiac magnetic resonance imaging, echocardiograms, and blood tests for heart-related biomarkers at specified days up to 360 days after treatment. Researchers observe the occurrence of cardiovascular events, measure heart function, and monitor safety outcomes throughout the trial period. Participants are followed to evaluate both short-term and longer-term effects of the treatment compared to placebo.

CONDITIONS

Brief Title

Efficacy and Safety of a Half-dose Bolus of r-SAK Prior to Primary PCI in ST-elevation Myocardial Infarction

Research Team

C

Chunjian Li, PHD

C

Chen Li, MD

Not the Right Trial for You?

Explore thousands of other clinical trials that might be a better match.
Sign up to get personalized trial recommendations delivered to your inbox.

Already have an account? Log in here